Published in Eur J Clin Microbiol Infect Dis on April 01, 2007
Combined real-time PCR and rpoB gene pyrosequencing for rapid identification of Mycobacterium tuberculosis and determination of rifampin resistance directly in clinical specimens. J Clin Microbiol (2010) 1.37
Multicenter evaluation of a transcription-reverse transcription concerted assay for rapid detection of mycobacterium tuberculosis complex in clinical specimens. J Clin Microbiol (2009) 0.82
Sputum digestion and decontamination with N-acetyl-L-cysteine-sodium hydroxide for culture of mycobacteria. Am Rev Respir Dis (1963) 9.11
Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev (2006) 6.03
Comparison of the ABI 7700 system (TaqMan) and competitive PCR for quantification of IS6110 DNA in sputum during treatment of tuberculosis. J Clin Microbiol (1998) 2.91
Rapid diagnosis of extrapulmonary tuberculosis by PCR: impact of sample preparation and DNA extraction. J Clin Microbiol (2003) 1.91
Multicenter evaluation of a pathogenic mycobacterium screening probe. J Clin Microbiol (2001) 0.82
Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J Exp Med (1974) 5.73
Influence of dose and route of antigen injection on the immunological induction of T cells. J Exp Med (1974) 4.99
Immunopotentiation with BCG. II. Modulation of the response to sheep red blood cells. J Natl Cancer Inst (1973) 4.10
Immunopotentiation with BCG. I. Immune response to different strains and preparations. J Natl Cancer Inst (1973) 3.20
Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob Agents Chemother (1998) 3.17
Feedback inhibition of specifically sensitized lymphocytes. J Exp Med (1974) 3.11
A novel integron in Salmonella enterica serovar Enteritidis, carrying the bla(DHA-1) gene and its regulator gene ampR, originated from Morganella morganii. Antimicrob Agents Chemother (2000) 2.85
Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 beta-lactamase and which were isolated in 14 French hospitals. J Clin Microbiol (1994) 2.66
Molecular characterisation by PCR-restriction fragment length polymorphism of TEM beta-lactamases. FEMS Microbiol Lett (1995) 2.63
Outbreak of Klebsiella pneumoniae producing transferable AmpC-type beta-lactamase (ACC-1) originating from Hafnia alvei. FEMS Microbiol Lett (2000) 2.57
Chromosomal beta-lactamase genes of Klebsiella oxytoca are divided into two main groups, blaOXY-1 and blaOXY-2. Antimicrob Agents Chemother (1996) 2.48
Evaluation of the automated phoenix system for potential routine use in the clinical microbiology laboratory. J Clin Microbiol (2004) 2.43
The modifying effect of BCG on the immunological induction of T cells. J Exp Med (1974) 2.30
An evaluation of the polymerase chain reaction amplicor Chlamydia trachomatis in male urine and female urogenital specimens. Sex Transm Dis (1994) 2.26
Characterisation of CMY-4, an AmpC-type plasmid-mediated beta-lactamase in a Tunisian clinical isolate of Proteus mirabilis. FEMS Microbiol Lett (1998) 2.09
Origin and impact of plasmid-mediated extended-spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis (1994) 1.94
Rapid diagnosis of extrapulmonary tuberculosis by PCR: impact of sample preparation and DNA extraction. J Clin Microbiol (2003) 1.91
Characterization of FOX-3, an AmpC-type plasmid-mediated beta-lactamase from an Italian isolate of Klebsiella oxytoca. Antimicrob Agents Chemother (1998) 1.85
False-positive HIV antigens related to emergence of a 25-30 kD protein detected in organ recipients. AIDS (1992) 1.82
Susceptibility to leprosy is linked to the human NRAMP1 gene. J Infect Dis (1998) 1.79
A stable form of delayed-type hypersensitivity. J Exp Med (1975) 1.68
An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon. Proc Natl Acad Sci U S A (1997) 1.55
Point mutation in the pribnow box, the molecular basis of beta-lactamase overproduction in Klebsiella oxytoca. Antimicrob Agents Chemother (1995) 1.53
beta-lactamase gene promoters of 71 clinical strains of Klebsiella oxytoca. Antimicrob Agents Chemother (1996) 1.47
Leprosy and BCG in southern Vietnam. Lancet (1990) 1.44
Deficit of interleukin 2 production associated with impaired T-cell proliferative responses in Mycobacterium lepraemurium infection. Infect Immun (1983) 1.42
The immunology of leprosy: speculations on the leprosy spectrum. Rev Infect Dis (1981) 1.38
Effects of bacterial lipopolysaccharide on the induction and expression of cell-mediated immunity. I. Depression of the afferent arc. J Immunol (1975) 1.37
Plasmid-mediated rifampin resistance encoded by an arr-2-like gene cassette in Klebsiella pneumoniae producing an ACC-1 class C beta-lactamase. Antimicrob Agents Chemother (2001) 1.31
Klebsiella oxytoca: resistance to aztreonam by overproduction of the chromosomally encoded beta-lactamase. FEMS Microbiol Lett (1994) 1.30
Granulomatous reaction to intradermal injection of lepromin (Mitsuda reaction) is linked to the human NRAMP1 gene in Vietnamese leprosy sibships. J Infect Dis (2000) 1.25
Local immune response to Mycobacterium lepraemurium in C3H and C57Bl/6 mice. Clin Exp Immunol (1979) 1.24
Systemic candidiasis in mice. II.--Main role of polymorphonuclear leukocytes in resistance to infection. Ann Immunol (Paris) (1980) 1.23
Viability, heat stability and immunogenicity of four BCG vaccines prepared from four different BCG strains. Ann Immunol (Paris) (1983) 1.23
Lactobacillus species identification, H2O2 production, and antibiotic resistance and correlation with human clinical status. J Clin Microbiol (1999) 1.22
Diagnosis of prosthetic joint infection by beadmill processing of a periprosthetic specimen. Clin Microbiol Infect (2010) 1.12
The stability and immunogenicity of a dispersed-grown freeze-dried Pasteur BCG vaccine. J Biol Stand (1988) 1.12
Effects of bacterial lipopolysaccharide on the induction and expression of cell-mediated immunity. II. Stimulation of the efferent arc. J Immunol (1975) 1.11
Site of action of serum factors that block delayed-type hypersensitivity in mice. J Exp Med (1978) 1.07
Complex segregation analysis of leprosy in southern Vietnam. Genet Epidemiol (1995) 1.06
Comparative in vitro activities of pristinamycin, its components, and other antimicrobial agents against anaerobic bacteria. Antimicrob Agents Chemother (1988) 1.04
IgG subclass distribution of antibody responses to protein and polysaccharide mycobacterial antigens in leprosy and tuberculosis patients. Clin Exp Immunol (1998) 1.03
Detection of SHV-5 extended-spectrum beta-lactamase in Klebsiella pneumoniae strains isolated in Italy. Eur J Clin Microbiol Infect Dis (1996) 1.01
Kinetics of circulating antibodies, immune complex and specific antibody-secreting cells in tuberculosis patients during 6 months of antimicrobial therapy. Tuber Lung Dis (2000) 0.99
Systemic candidiasis in mice. I.--Correlation between kidney infection and mortality rate. Ann Immunol (Paris) (1980) 0.99
Immunological behavior after mycobacterial infection in selected lines of mice with high or low antibody responses. Infect Immun (1979) 0.98
Delayed-type hypersensitivity to rabies virus in mice: assay of active or passive sensitization by the footpad test. Infect Immun (1978) 0.98
Different time course patterns of local expression of delayed-type hypersensitivity to sheep red blood cells in mice. Cell Immunol (1992) 0.98
Influence of dose and route of Mycobacterium lepraemurium inoculation on the production of interleukin 1 and interleukin 2 in C57BL/6 mice. Infect Immun (1984) 0.97
Restoration of cell-mediated immunity to animals blocked by a humoral response. J Exp Med (1974) 0.96
In-vitro susceptibility of Klebsiella oxytoca strains to 13 beta-lactams in the presence and absence of beta-lactamase inhibitors. J Antimicrob Chemother (1996) 0.96
Strain variation of lymphokine production and specific antibody secretion in mice infected with Mycobacterium lepraemurium. Cell Immunol (1985) 0.96
Epidemic Pseudomonas aeruginosa serotype O16 bacteremia in hematology-oncology patients. J Clin Microbiol (1989) 0.95
A one-year prospective study (1994-1995) for a first evaluation of tuberculosis transmission in French prisons. Int J Tuberc Lung Dis (2000) 0.94
[Delayed local reaction (DLR) after BCG vaccination in mice. II.--Correlations with the immune response (author's transl)]. Ann Immunol (Paris) (1978) 0.94
Relapses after stopping chemotherapy for experimental tuberculosis in genetically resistant and susceptible strains of mice. Clin Exp Immunol (1989) 0.93
Novel, plasmid-encoded, TEM-derived extended-spectrum beta-lactamase in Klebsiella pneumoniae conferring higher resistance to aztreonam than to extended-spectrum cephalosporins. Antimicrob Agents Chemother (1993) 0.92
Delayed-type hypersensitivity and acquired resistance to plague in mice immunized with killed Yersinia pestis and immunoregulators. Immunology (1981) 0.92
Immunological mechanisms controlling mycobacterial infections. Bull Eur Physiopathol Respir (1983) 0.91
In vivo detection of specific cell-mediated immunity in street rabies virus infection in mice. J Gen Virol (1980) 0.90
[Inflammation and resistance of mice infected by "Candida albicans" (author's transl)]. Ann Immunol (Paris) (1979) 0.90
Modulation by malaria infection of the induction of T lymphocyte-dependent delayed-type hypersensitivity and antibody formation to sheep erythrocytes in mice. Parasite Immunol (1979) 0.90
In vitro activity of cefoxitin and imipenem against Mycobacterium abscessus complex. Clin Microbiol Infect (2013) 0.90
Synergic inhibitory activity of amphotericin-B and gamma interferon against intracellular Cryptococcus neoformans in murine macrophages. J Antimicrob Chemother (1994) 0.89
Circulating immune complexes in human tuberculosis sera: demonstration of specific antibodies against Mycobacterium tuberculosis glycolipid (DAT, PGLTb1, LOS) antigens in isolated circulating immune complexes. Eur J Clin Invest (1997) 0.88
In vivo antitumor activity of various forms of delayed-type hypersensitivity in mice. J Natl Cancer Inst (1979) 0.88
Studies of the thymus in Chagas' disease: III. Colonization of the thymus and other lymphoid organs of adult and newborn mice by Trypanosoma cruzi. Pathol Biol (Paris) (1991) 0.87
Surface Lyt phenotype of suppressor cells in C57BL/6 mice infected with Mycobacterium lepraemurium. Clin Exp Immunol (1983) 0.87
Trypanosoma cruzi infection in immunosuppressed mice. Immunol Lett (1992) 0.87
Role of T lymphocytes in the resistance and immunopathology of experimental Chagas' disease. I. Histopathological studies. Ann Immunol (Paris) (1984) 0.86
[Delayed type hypersensitivity reactions to "Candida albicans" in mice (author's transl)]. Ann Immunol (Paris) (1979) 0.86
Protective immunity to chronic bacterial infection. Scand J Immunol (1979) 0.86
Analysis of circulating immune complexes (CICs) in childhood tuberculosis: levels of specific antibodies to glycolipid antigens and relationship with serum antibodies. Int J Tuberc Lung Dis (2000) 0.85
Preliminary evaluation of a Mycobacterium tuberculosis lipooligosaccharide (LOS) antigen in the serological diagnosis of tuberculosis in HIV seropositive and seronegative patients. Tuber Lung Dis (1995) 0.84
Trypanosoma cruzi: infection patterns in intact and athymic mice of susceptible and resistant genotypes. Histol Histopathol (2002) 0.84
[Delayed local reaction (DLR) after BCG vaccination in mice. I.--Description (author's transl]. Ann Immunol (Paris) (1978) 0.82
Anti-PGL-Tb1 responses as an indicator of the immune restoration syndrome in HIV-TB patients. Tuberculosis (Edinb) (2008) 0.82
Natural resistance to mycobacteria: antimicrobial activity and reactive oxygen intermediate releasing functions of murine macrophages. Ann Immunol (Paris) (1984) 0.82
Multicenter evaluation of a pathogenic mycobacterium screening probe. J Clin Microbiol (2001) 0.82
[Action of teicoplanin on coagulase negative staphylococci in hospital units of the hospital Hôtel-Dieu in Paris]. Pathol Biol (Paris) (1993) 0.82
[Automated RNA amplification for the rapid identification of Mycobacterium tuberculosis complex in respiratory specimens]. Pathol Biol (Paris) (2006) 0.82
Multicenter evaluation of a transcription-reverse transcription concerted assay for rapid detection of mycobacterium tuberculosis complex in clinical specimens. J Clin Microbiol (2009) 0.82
Comparative effects of carrageenan on systemic candidiasis and listeriosis in mice. Clin Exp Immunol (1981) 0.82
Comparison between immunopotency tests and specific active or passive acquired resistance against Mycobacterium tuberculosis in mice induced with three different preparations of BCG pasteur vaccine. Clin Exp Immunol (1983) 0.81
[Inflammation and resistance of mice against "Plasmodium berghei" (author's transl)]. Ann Immunol (Paris) (1982) 0.81
The influence of BCG vaccination on murine leprosy in C57BL/6 and C3H mice. Ann Immunol (Paris) (1980) 0.81
Patient nostril microbial flora: individual-dependency and diversity precluding prediction of Staphylococcus aureus acquisition. Clin Microbiol Infect (2013) 0.81
Analysis of the immunological humoral response to Mycobacterium tuberculosis glycolipid antigens (DAT, PGLTb1) for diagnosis of tuberculosis in HIV-seropositive and -seronegative patients. Eur J Clin Microbiol Infect Dis (1995) 0.81
TNF alpha, IL-1 beta and IL-6 plasma levels in neutropenic patients after onset of fever and correlation with the C-reactive protein (CRP) kinetic values. Infection (1995) 0.80
Trypanosoma cruzi: histopathology of endocrine system in immunocompromised mice. Int J Exp Pathol (1994) 0.80
Comparative studies of different strains of BCG vaccine in mice: T-cell dependent immune responses. Dev Biol Stand (1978) 0.80
Effects of suramin on the in vivo antimicrobial resistance against Listeria monocytogenes and Mycobacterium bovis (BCG) in mice. Clin Exp Immunol (1986) 0.80
Various strains of BCG vaccine and genetic control of the immune response of mice. Dev Biol Stand (1986) 0.79
Induction of protective immunity to mycobacterial infections. Lepr Rev (1986) 0.79
Preliminary evidence of natural resistance to Mycobacterium bovis (BCG) in lepromatous leprosy. Int J Lepr Other Mycobact Dis (1984) 0.78
Protective effect of BCG against leprosy and its subtypes: a case-control study in southern Vietnam. Int J Lepr Other Mycobact Dis (1994) 0.78
Tuberculosis in European cities: establishment of a patient monitoring system over 10 years in Paris, France. Int J Tuberc Lung Dis (2007) 0.78
Human immunodeficiency virus infection alters antigen-induced cytokine responses in patients with active mycobacterial diseases. J Infect Dis (1998) 0.78